.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown varied performance across different product categories in Ohio. In the Edible category, the brand has struggled to secure a spot in the top 30, with its ranking fluctuating between 40th and 47th from September to December 2025. This inconsistency suggests challenges in maintaining a strong presence in the market, although a slight improvement was observed in December. Conversely, in the Flower category, Farmaceutical Rx (Frx) has demonstrated a more dynamic performance. The brand climbed from 33rd in September to an impressive 21st in November, indicating a significant uptick in consumer preference, before experiencing a drop to 39th in December. This movement highlights both the potential and volatility in the Flower category for the brand.
While Farmaceutical Rx (Frx) has not consistently ranked within the top 30 in the Edible category, their Flower products have shown promising trends in Ohio. Notably, the brand's Flower sales saw a substantial increase in November, suggesting a growing consumer interest or successful marketing strategies during that period. However, the subsequent decline in December raises questions about sustainability and market competition. The brand's ability to navigate these fluctuations will be crucial for maintaining and improving its market position in Ohio's competitive cannabis landscape. These insights provide a glimpse into the brand's current standing, with further analysis needed to fully understand the underlying factors influencing these trends.
Competitive Landscape
In the competitive landscape of the Ohio flower category, Farmaceutical Rx (Frx) experienced fluctuating rankings from September to December 2025, reflecting a dynamic market environment. Notably, Farmaceutical Rx (Frx) achieved its highest ranking at 21st place in November, driven by a significant increase in sales, before dropping to 39th in December. This volatility contrasts with competitors like Roll One / R.O., which maintained a relatively stable position, peaking at 29th in October and ending the period at 38th. Meanwhile, The Solid consistently outperformed Farmaceutical Rx (Frx), despite a downward trend from 24th in September to 37th in December. Seeker and HillFire also exhibited varied performances, with Seeker failing to break into the top 20 throughout the period and HillFire maintaining a steady presence just outside the top 40. These insights suggest that while Farmaceutical Rx (Frx) has the potential for strong sales surges, its market position remains susceptible to competitive pressures and market dynamics in Ohio.
Notable Products
In December 2025, Animal Face (2.83g) emerged as the top-performing product for Farmaceutical Rx (Frx), marking its debut at rank 1 with sales of 552 units. GMO Minis (5.66g) followed closely at rank 2, a slight drop from its previous top position in November. White Truffle (2.83g) maintained its position at rank 2 from November, sharing the spot with GMO Minis, indicating consistent performance. Strawberry Float #7 (2.83g) retained its rank 3 position from November, showing a slight decrease in sales figures. Milkbone (2.83g), appearing for the first time, entered at rank 4, suggesting a strong initial reception in the market.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
